Jefferies has downgraded Dentsply Sirona (NASDAQ:XRAY) to hold from buy, citing ongoing macro headwinds and company-specific issues. The investment bank noted that macro issues have negatively impacted results in the dental sector,

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares faced a downgrade in stock rating by Jefferies from Buy to Hold, with a significant reduction in the price target to $20.00 from the previous $30.00. The firm's analysts cited a notably negative shift in sentiment towards the company,

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.44 which represents a slight increase of $0.08 or 0.41% from the prior close of $19.36. The stock opened at $19.19 and touched a low of $18.

Jefferies analyst Glen Santangelo downgraded Dentsply Sirona (XRAY) to Hold from Buy with a price target of $20, down from $30. Investor

Fintel reports that on January 23, 2025, Jefferies downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from Buy to Hold. Analyst Price Forecast Suggests 21.99% Upside As of December 23, 2024,